Zusammenfassung

• Objekte (1 geändert, 0 hinzugefügt, 0 gelöscht)
  • Wikiderm.EntryClass[0]

Details

Wikiderm.EntryClass[0]

Eintrag

...	...	@@ -59,17 +59,62 @@
59	59	(% class="Bullet" %)-(%%) Pyoderma gangraenosum
60	60
61	61	(% class="Eintrag-2" %)
62		-(% class="Feature" %)TF:(%%) Infekte
	62	+(% class="Feature" %)TF:(%%) (% class="Bullet" %)-(%%) Infekte
63	63
64	64	(% class="Ebene-2" %)
65	65	(% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV
66	66
	67	+(% class="Ebene-1" %)
	68	+(% class="Bullet" %)-(%%) Dupilumab
	69	+
	70	+(% class="Ebene-2" %)
	71	+(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2023 Nov 27. [[http:~~/~~/doi.org/10.1111/ajd.14190>>url:http://doi.org/10.1111/ajd.14190]]
	72	+
67	67	(% class="Eintrag-2" %)
68		-(% class="Feature" %)DD:(%%) (% class="Abbreviation" %)AGEP(%%), Dermatitis herpetiformis, eosinophile pustulöse Follikulitis Ofuji, Impetigo contagiosa, Pemphigus foliaceus, Psoriasis pustulosa
	74	+(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%)
69	69
	76	+(% class="Ebene-1" %)
	77	+(% class="Bullet" %)-(%%) Dermatitis herpetiformis
	78	+
	79	+(% class="Ebene-1" %)
	80	+(% class="Bullet" %)-(%%) eosinophile pustulöse Follikulitis Ofuji
	81	+
	82	+(% class="Ebene-1" %)
	83	+(% class="Bullet" %)-(%%) Impetigo contagiosa
	84	+
	85	+(% class="Ebene-1" %)
	86	+(% class="Bullet" %)-(%%) Pemphigus foliaceus
	87	+
	88	+(% class="Ebene-1" %)
	89	+(% class="Bullet" %)-(%%) anuläre Psoriasis pustulosa
	90	+
	91	+(% class="Ebene-2" %)
	92	+(% class="Feature" %)Bsp:(%%) annular pustular psoriasis
	93	+
	94	+(% class="Ebene-2" %)
	95	+(% class="Feature" %)Lit:(%%) Pediatr Dermatol. 2023 Jan 31. [[http:~~/~~/doi.org/10.1111/pde.15251>>url:http://doi.org/10.1111/pde.15251]]
	96	+
	97	+(% class="Ebene-1" %)
	98	+(% class="Bullet" %)-(%%) Tinea incognito
	99	+
	100	+(% class="Ebene-2" %)
	101	+(% class="Feature" %)Lit:(%%) [[Kalkan, G., Demirseren, D. D, Güney, C. A, & Aktaş, A. (2020). A case of tinea incognito mimicking subcorneal pustular dermatosis. Dermatology Online Journal, 26(2)>>url:https://escholarship.org/uc/item/46g9x55w]]
	102	+
70	70	(% class="Eintrag-2" %)
71		-(% class="Feature" %)Lit:(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}}
	104	+(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}}
72	72
	106	+(% class="Ebene-1" %)
	107	+(% class="Bullet" %)-(%%) Open Access Maced J Med Sci. 2020 Jun 05; 8(T1):12-15. [[https:~~/~~/doi.org/10.3889/oamjms.2020.4870>>url:https://doi.org/10.3889/oamjms.2020.4870]]
	108	+
	109	+(% class="Ebene-1" %)
	110	+(% class="Bullet" %)-(%%) International Journal of Women's Dermatology, Volume 6, Issue 3, 2020, Pages 131-136, ISSN 2352-6475, [[https:~~/~~/doi.org/10.1016/j.ijwd.2020.02.003>>url:https://doi.org/10.1016/j.ijwd.2020.02.003]]
	111	+
	112	+(% class="Ebene-1" %)
	113	+(% class="Bullet" %)-(%%) SAGE Open Med Case Rep. 2019 Jan 30;7:2050313X19826432. [[http:~~/~~/doi.org/10.1177/2050313X19826432>>url:http://doi.org/10.1177/2050313X19826432]]
	114	+
	115	+(% class="Ebene-1" %)
	116	+(% class="Bullet" %)-(%%) JAAD Case Rep. 2022 Jan 21;21:185-188. [[http:~~/~~/doi.org/10.1016/j.jdcr.2021.04.039>>url:http://doi.org/10.1016/j.jdcr.2021.04.039]]
	117	+
73	73	(% class="Eintrag-2" %)
74	74	(% class="Feature" %)Th:(%%) (% class="Bullet" %)-(%%) lokal
75	75
...	...	@@ -77,6 +77,12 @@
77	77	(% class="Bullet" %)-(%%) Farbstoffe (**[[Antiseptika]]**)
78	78
79	79	(% class="Ebene-2" %)
	125	+(% class="Bullet" %)-(%%) Mometasonfuroat
	126	+
	127	+(% class="Ebene-3" %)
	128	+(% class="Feature" %)Lit:(%%) Dermatol Ther. 2021 Nov 27:e15235. [[http:~~/~~/doi.org/10.1111/dth.15235>>url:http://doi.org/10.1111/dth.15235]]
	129	+
	130	+(% class="Ebene-2" %)
80	80	(% class="Bullet" %)-(%%) Tacalcitol
81	81
82	82	(% class="Ebene-3" %)
...	...	@@ -155,14 +155,8 @@
155	155	(% class="Feature" %)Stoff:(%%) (% class="Bullet" %)-(%%) **[[Infliximab]]**
156	156
157	157	(% class="Ebene-4" %)
158		-(% class="Feature" %)Phar:(%%) Remicade^^®^^
	209	+(% class="Feature" %)Lit:(%%) Arch Dermatol 2001; 137: 1571-4, Dermatol Ther. 2022 May 4:e15552. [[http:~~/~~/doi.org/10.1111/dth.15552>>url:http://doi.org/10.1111/dth.15552]]
159	159
160		-(% class="Ebene-4" %)
161		-(% class="Feature" %)Dos:(%%) 5 mg/kg i.v.
162		-
163		-(% class="Ebene-4" %)
164		-(% class="Feature" %)Lit:(%%) Arch Dermatol 2001; 137: 1571-4
165		-
166	166	(% class="Ebene-3" %)
167	167	(% class="Bullet" %)-(%%) Adalimumab
168	168
...	...	@@ -170,4 +170,11 @@
170	170	(% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich)
171	171
172	172	(% class="Ebene-5" %)
173		-(% class="Feature" %)PT:(%%) CR
	218	+(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
	219	+
	220	+(% class="Ebene-2" %)
	221	+(% class="Bullet" %)-(%%) Guselkumab
	222	+
	223	+(% class="Ebene-3" %)
	224	+(% class="Feature" %)Lit:(%%) Int J Dermatol. 2021 Apr;60(4):e153-e154. [[http:~~/~~/doi.org/10.1111/ijd.15311>>url:http://doi.org/10.1111/ijd.15311]]
	225	+